Author(s):
Ramanamoorthy Kandula, Rupali S. Jain, Sandhya Kandula, B. Surendranath Reddy
Email(s):
ramana.kandula@gmail.com , rupalisjain@gmail.com , sandhyatalla12@gmail.com , surendra.phd@gmail.com
DOI:
10.52711/0974-360X.2023.00687 
Address:
Ramanamoorthy Kandula1,2*, Rupali S. Jain2, Sandhya Kandula3, B. Surendranath Reddy2
1Assistant Professor, Department of Mathematics, B V Raju Institute of Technology, Narsapur, Medak - Dist. T.S., India - 502313.
2Assistant Professor, Department of Mathematics, Swami Ramanand Teerth Marathwada University, Nanded, M.S., India - 431606.
3Assistant Professor, Department of Pharmacology, Vishnu Institute of Pharmaceutical Education and Research, Narsapur, Medak - Dist., T.S., India - 502313.
*Corresponding Author
Published In:
Volume - 16,
Issue - 9,
Year - 2023
ABSTRACT:
The insulin-like growth factor-1 (IGF-1) is a peptide hormone that is regulated by growth hormone and secreted in the liver; its prime role is to regulate the growth and proliferation of the bone cell. Our study results relate to the cause of bone cancer due to high IGF-1 levels in liver metastatic conditions. Liver cancer increases the liver volume which further increases IGF-1 secretion to a toxic level, which in turn causes uncontrolled bone cell proliferation and maturation thus leading to bone cancer. Thus, the mathematical model was designed to explain the kinetics of IGF-1 from the liver to bone and mathematically simplified using the ordinary differential equation, and IGF-1 concentration was estimated in the normal and cancerous state. The mathematical simulation was done using a high throughput technique using MATLAB (version R2020a). The model parameter condition due to liver cancer is considered as an increase in liver volume (vL), The initial mass of IGF-1(x01), and the varying rate constants (kP, kL, ke1, and ke2). The graphical results represent the volume of the liver and synthesis of IGF-1 increases with varying abnormal rate constants giving the estimation of an increase in IGF-1 concentration in plasma, and more IGF-1 deposits over the bone to a toxic level.
Cite this article:
Ramanamoorthy Kandula, Rupali S. Jain, Sandhya Kandula, B. Surendranath Reddy. Mathematical Model of Insulin-like growth factor-1 estimating its cause in human bone cancer arises due to liver cancer. Research Journal of Pharmacy and Technology 2023; 16(9):4199-4205. doi: 10.52711/0974-360X.2023.00687
Cite(Electronic):
Ramanamoorthy Kandula, Rupali S. Jain, Sandhya Kandula, B. Surendranath Reddy. Mathematical Model of Insulin-like growth factor-1 estimating its cause in human bone cancer arises due to liver cancer. Research Journal of Pharmacy and Technology 2023; 16(9):4199-4205. doi: 10.52711/0974-360X.2023.00687 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-9-31
REFERENCE:
1. Kmieć, Z., Cooperation of Liver Cells in the Synthesis of Growth Factors and Respective Binding Proteins. In Cooperation of Liver Cells in Health and Disease. 2001; 73-78. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56553-3_11
2. Chiquita Prahasanti, Sonny Perdana. The Roles of Insulin Growth Factors-1 (IGF-1) in Bone Graft to increase Osteogenesis. Research Journal of Pharmacy and Technology. 2022; 15(4):1737-2. DOI: 10.52711/0974-360X.2022.00291
3. Schwander, J.C., Hauri, C., Zapf, J. and Froesch, E.R., Synthesis, and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology. 1983; 113(1): 297-305. https://doi.org/10.1210/endo-113-1-297
4. Wu, Y., Brodt, P., Sun, H., Mejia, W., Novosyadlyy, R., Nunez, N., Chen, X., Mendoza, A., Hong, S.H., Khanna, C. and Yakar, S., Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis. Cancer Research. 2010; 70(1):57-67.https://doi.org/10.1158/0008-5472.CAN-09-2472.
5. Fürstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol. 2002; 3(5): 298-302. doi:10.1016/s1470-2045(02)00731-3.
6. Boroujerdi, M.A., Sonksen, P.H. and Jones, R.H., 1994. A compartmental model for simulation of IGF-I kinetics and metabolism. Methods of Information in Medicine. 1994; 33(05): 514-521. DOI: 10.1055/s-0038-1635049
7. Phillips, G.M., Shorten, P.R., Wake, G.C., and Guan, J., Modeling the effect of insulin-like growth factor-1 on human cell growth. Mathematical Biosciences. 2015; 259:43-54. https://doi.org/10.1016/j.mbs.2014.11.002
8. Rieunier, G., Wu, X., Macaulay, V.M., Lee, A.V., Weyer-Czernilofsky, U. and Bogenrieder, T., Bad to the bone: the role of the insulin-like growth factor axis in osseous metastasis. Clinical Cancer Research. 2019; 25(12): 3479-3485. https://doi.org/10.1158/1078-0432.CCR-18-2697
9. K. T. N. Jyothi, P. S. R. Subrahmanyam, A. Ch. Sravanthi. Application of Differential Equations in Medical Science. Research J. Science and Tech. 2017; 9(3): 425-426. DOI: 10.5958/2349-2988.2017.00074.2
10. M.A. Bondarenko, V.G. Knigavko, O.V. Zaytseva, A.Yu. Nikonov, G.A. Kovalenko. New Conceptual Interpretations of Mechanisms for the Repair of Double-Strand DNA Breaks and Their Mathematical Modeling. Research J. Pharm. and Tech. 2020; 13(1): 429-435. DOI: 10.5958/0974-360X.2020.00084.0
11. Goverdhan Reddy. J, Sita Rambabu. B. A Mathematical Study of Two Species Commensalism Model. Research J. Science and Tech. 2017; 9(3):385-391. DOI: 10.5958/2349-2988.2017.00067.5
12. Subhashini Rajakumaran, Ruth Christiya C. Anti-proliferative effects of Euphorbia hirta L on the activity of cytotoxicity in bone cancer MG-63 cells. Research Journal of Pharmacy and Technology. 2021; 14(4): 2221-3. DOI: 10.52711/0974-360X.2021.00394
13. Sami Ali, Rana Makhous. Evaluation of the effect of Simvastatin Therapy on Bone remodeling in Rats. Research Journal of Pharmacy and Technology. 2022; 15(2): 525-8. DOI: 10.52711/0974-360X.2022.00084.
14. Gopala Krishna Ganta, Rama Krishna Alla, Kamala Cheruvu, Bharathi Ram Guduri. Bone Grafts: An Overview of Bone Remodeling, Types and Recent Advances. Research Journal of Pharmacy and Technology. 2021; 14(11): 6101-5. DOI: 10.52711/0974-360X.2021.01060
15. Subhashis Debnath, T. H. Harish Kumar. An Overview on Pharmacokinetics and Pharmacokinetic Modeling. Asian J. Res. Pharm. Sci. 2020; 10(2): 124-130. DOI: 10.5958/2231-5659.2020.00023.5
16. Grahnen, A., Kastrup, K., Heinrich, U., Gourmelen, M., Preece, M.A., Vaccarello, M.A., Guevara‐Aguirre, J., Rosenfeld, R.G. and Sietnieks, A., Pharmacokinetics of recombinant human insulin‐like growth factor I gave subcutaneously to healthy volunteers and patients with growth hormone receptor deficiency. Acta Paediatrica.1993; 82: 9-13.https://doi.org/10.1111/j.1651-2227.1993.tb12918.x
17. Frystyk, J., Hussain, M., Skjaerbaek, C., Pørksen, N., Froesch, E.R. and Ørskov, H., The pharmacokinetics of free insulin-like growth factor-I in healthy subjects. Growth Hormone and IGF Research. 1999; 9(2): 150-156. https://doi.org/10.1054/ghir.1999.0100
18. Carlsson, G., Gullberg, B. and Hafström, L.O., Estimation of liver tumor volume using different formulas—an experimental study in rats. Journal of Cancer Research and Clinical Oncology. 1983; 105(1): 20-23. https://doi.org/10.1007/BF00391826
19. Leung, N.W.Y., Farrant, P. and Peters, T.J., Liver volume measurement by ultrasonography in normal subjects and alcoholic patients. Journal of Hepatology. 1986; 2(2):157-164. https://doi.org/10.1016/S0168-8278(86)80074-5
20. Carretero, J.M., Rodríguez, L., García‐González, R., Quam, R.M. and Arsuaga, J.L., Exploring bone volume and skeletal weight in the Middle Pleistocene humans from the Sima de losHuesos site (Sierra de Atapuerca, Spain). Journal of Anatomy. 2018; 233(6):740-754.https://doi.org/10.1111/joa.12886
21. Adamek A, Kasprzak A. Insulin-Like Growth Factor (IGF) System in Liver Diseases. Int J Mol Sci. 2018; 19(5): 1308.https://doi.org/10.3390/ijms19051308
22. Rabkin, Ralph, Fernando C. Fervenza, Helen Maidment, John Ike, Raymond Hintz, Frances Liu, Duane C. Bloedow, Andrew R. Hoffman, and Neil Gesundheit., Pharmacokinetics of insulin-like growth factor-1 in advanced chronic renal failure., Kidney International. 1996; 49 (4): 1134-1140. https://doi.org/10.1038/ki.1996.164
23. Vaccarello, Mary A., F. B. Diamond Jr, Jaime Guevara-Aguirre, Arlan L. Rosenbloom, Paul J. Fielder, Sharron Gargosky, Pinchas Cohen, Kristin Wilson, and Ron G. Rosenfeld. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome., The Journal of Clinical Endocrinology and Metabolism. 1993; 77 (1): 273-280. https://doi.org/10.1210/jcem.77.1.7686916.
24. Wilton, P., A. Sietnieksi, R. Gunnarssoni, L. Berger, and A. Grahnen. Pharmacokinetic profile of recombinant human insulin‐like growth factor I given subcutaneously in normal subjects., Acta Paediatrica. 1991; 80:111-114. https://doi.org/10.1111/apa.1991.80.s377.111
25. Lee, W.H. and Okos, M.R., Model-based analysis of IGF-1 effect on osteoblast and osteoclast regulation in bone turnover. Journal of Biological Systems. 2016; 24(01):63-89. https://doi.org/10.1142/S0218339016500042
26. Kandula, R., Jain, R.S., Kandula, S., and Reddy, B.S., Compartmental model to estimate bile acid concentration in different clinical manifestations. Indian Journal of Science and Technology. 2021; 14(18): 1422-1433. https://doi.org/ 10.17485/IJST/v14i18.434.